Haleon Plc slid the most in nearly one year after sales grew less than expected in 2025, as a weak cold and flu season meant fewer customers purchased its over-the-counter medicines.
Haleon Plc slid the most in nearly one year after sales grew less than expected in 2025, as a weak cold and flu season meant fewer customers purchased its over-the-counter medicines.
The maker of Panadol and Advil painkillers said Wednesday that sales increased by 3% in 2025. Photographer: Daniel Acker/Bloomberg
Anmelden
